XML 43 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED AND COMBINED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
5 Months Ended 7 Months Ended 12 Months Ended
Dec. 31, 2015
Jul. 31, 2015
Dec. 31, 2017
Dec. 31, 2016
Net income (loss) $ (14,437)   $ 23,562 $ (111,560)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Depreciation and amortization 19,434   44,356 42,850
Provision for bad debts 190   308 1,052
Stock based compensation for equity classified awards 1,124   1,886 3,250
Pension (income) expense 119   (153) 188
Amortization of inventory fair value adjustment 73,054   0 30,377
Amortization of deferred financing cost 911   2,368 2,275
Transaction costs (4,487)   0 0
Accretion of contingent consideration 11,862   8,433 30,197
Decrease in fair value of contingent consideration (23,692)   (26,948) (53,608)
Deferred income taxes (19,886)   (12,515) 13,792
Impairment of long-lived assets 0   0 10,795
Goodwill impairment 0   0 62,373
Loss (gain) on sales of property 0   81 22
Other 2,556   98 32
Changes in operating assets and liabilities:        
Accounts receivable (42,703)   5,981 (4,101)
Inventories 2,288   (2,496) (764)
Prepaid expenses and other current assets (3,830)   (5,176) (7,788)
Accounts payable 13,785   (13,889) 6,357
Accrued expenses and other liabilities 2,492   18,432 2,341
Income taxes payable 0   2,844 (376)
Other assets and liabilities 0   (11,783) 2,780
Net cash provided by (used in) operating activities 18,780   35,389 30,484
Cash flows from investing activities:        
Cash paid for property and equipment (516)   (7,725) (6,004)
Proceeds from sale of property 0   99 76
Acquisition of business, net of cash acquired (625,541)   (18,192) 0
Restricted cash 220,505   0 0
Other investments 0   (11,132) (600)
Net cash used in investing activities (405,552)   (36,950) (6,528)
Cash flows from financing activities:        
Proceeds from long term debt 425,000   0 0
Payment of debt issuance costs (13,120)   0 0
Payment of revolving credit facility fees (1,266)   0 0
Other financing costs (7,776)   0 0
Payment of Dow liabilities settlement 0   (10,000) 0
Repayment of long term debt (2,125)   (4,015) (4,250)
Proceeds from private placement 50,000   0 0
Borrowings under revolving credit facility 500   0 0
Repayments of revolving credit facility (500)   0 0
Insurance premium financing 1,294   0 0
Repayment of notes payable (380)   0 0
Repurchase of stock for treasury (2,397)   (1,488)
Payment of withholding taxes related to stock-based compensation to employees 0   (331)
Repurchase of warrants (2,524)   0 0
Cash transfers to/from parent, net 0   0 0
Net cash (used in) provided by financing activities 446,706   (14,015) (6,069)
Effect of exchange rate changes on cash and cash equivalents (2,253)   2,797 1,660
Net (decrease) increase in cash and cash equivalents 57,681   (12,779) 19,547
Cash and cash equivalents, beginning of period     77,312 57,765
Cash and cash equivalents, end of period 57,765   64,533 77,312
Supplemental disclosures of cash flow information:        
Interest 10,411   18,884 24,560
Income taxes 0   3,257 3,095
Supplemental schedule of non-cash investing and financing activities:        
Accrued purchases of property and equipment 0   1,422 815
Issuance of common stock as consideration for acquisition of business 210,000   0 0
Acquisition-related contingent consideration 190,150   691 0
Settlement of Dow liabilities not resulting from a cash payment 0   $ 55,089 $ 0
Predecessor        
Net income (loss)   $ (14,057)    
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Depreciation and amortization   17,379    
Provision for bad debts   0    
Stock based compensation for equity classified awards   0    
Pension (income) expense   0    
Amortization of inventory fair value adjustment   0    
Amortization of deferred financing cost   0    
Transaction costs   0    
Accretion of contingent consideration   0    
Decrease in fair value of contingent consideration   0    
Deferred income taxes   (4,218)    
Impairment of long-lived assets   0    
Goodwill impairment   0    
Loss (gain) on sales of property   (12)    
Other   0    
Changes in operating assets and liabilities:        
Accounts receivable   42,585    
Inventories   (5,756)    
Prepaid expenses and other current assets   0    
Accounts payable   (798)    
Accrued expenses and other liabilities   0    
Income taxes payable   (36,070)    
Other assets and liabilities   (4,651)    
Net cash provided by (used in) operating activities   (5,598)    
Cash flows from investing activities:        
Cash paid for property and equipment   (676)    
Proceeds from sale of property   63    
Acquisition of business, net of cash acquired   0    
Restricted cash   0    
Other investments   0    
Net cash used in investing activities   (613)    
Cash flows from financing activities:        
Proceeds from long term debt   0    
Payment of debt issuance costs   0    
Payment of revolving credit facility fees   0    
Other financing costs   0    
Payment of Dow liabilities settlement   0    
Repayment of long term debt   0    
Proceeds from private placement   0    
Borrowings under revolving credit facility   0    
Repayments of revolving credit facility   0    
Insurance premium financing   0    
Repayment of notes payable   0    
Repurchase of stock for treasury   0    
Payment of withholding taxes related to stock-based compensation to employees   0    
Repurchase of warrants   0    
Cash transfers to/from parent, net   6,211    
Net cash (used in) provided by financing activities   6,211    
Effect of exchange rate changes on cash and cash equivalents   0    
Net (decrease) increase in cash and cash equivalents   0    
Cash and cash equivalents, beginning of period $ 0      
Cash and cash equivalents, end of period   0    
Supplemental disclosures of cash flow information:        
Interest   0    
Income taxes   0    
Supplemental schedule of non-cash investing and financing activities:        
Accrued purchases of property and equipment   0    
Issuance of common stock as consideration for acquisition of business   0    
Acquisition-related contingent consideration   0    
Settlement of Dow liabilities not resulting from a cash payment   $ 0